Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa

Cancer Research

Volumn 72, Issue 14, 2012, Pages 3522-3534

  Ng, Yi Zhen ^a,b   Pourreyron, Celine ^a   Salas Alanis, Julio C ^c   Dayal, Jasbani H S ^a   Cepeda Valdes, Rodrigo ^c   Yan, Wenfei ^d   Wright, Sheila ^a   Chen, Mei ^e   Fine, Jo David ^f   Hogg, Fiona J ^a   McGrath, John A ^g   Murrell, Dedee F ^d   Leigh, Irene M ^a   Lane, E Birgit ^b   South, Andrew P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 12; COLLAGEN TYPE 7; MESSENGER RNA; THROMBOSPONDIN 1; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INVASION; CELL ISOLATION; CELL PROLIFERATION; COL7A1 GENE; DISEASE ASSOCIATION; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FIBROBLAST CULTURE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECESSIVE EPIDERMOLYSIS BULLOSA DYSTROPHICA; SAMPLE; SKIN CARCINOMA; SKIN FIBROBLAST; TUMOR GROWTH; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE VII; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; SKIN; THROMBOSPONDIN 1; WNT PROTEINS;

EID: 84863914039     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-2996     Document Type: Article

References (50)

1. Christiano AM, Greenspan DS, Hoffman GG, Zhang X, Tamai Y, Lin AN, et al. A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet 1993;4: 62-6. (Pubitemid 23165915)
2. Burgeson RE. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 1993;101:252-5. (Pubitemid 23269892)
3. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-50.
4. Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009;60: 203-11.
5. South AP, O'Toole EA. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma. Dermatol Clin 2009;28:171-8.
6. Venugopal SS, Murrell DF. Treatment of skin cancers in epidermolysis bullosa. Dermatol Clin 2010;28:283-7, ix-x.
7. Arbiser JL, Fan CY, Su X, Van Emburgh BO, Cerimele F, Miller MS, et al. Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. J Invest Dermatol 2004;123:788-90. (Pubitemid 39281622)
8. Arbiser JL, Fine JD, Murrell D, Paller A, Connors S, Keough K, et al. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Mol Med 1998;4:191-5. (Pubitemid 28223970)
9. Cooper HL, Cook IS, Theaker JM, Mallipeddi R, McGrath J, Friedmann P, et al. Expression and glycosylation of MUC1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas. Br J Dermatol 2004;151:540-5. (Pubitemid 39330876)
10. Mallipeddi R, Wessagowit V, South AP, Robson AM, Orchard GE, Eady RA, et al. Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2004;122: 1302-9. (Pubitemid 38651107)
11. Pourreyron C, Cox G, Mao X, Volz A, Baksh N, Wong T, et al. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol 2007;127:2438-44. (Pubitemid 47619753)
12. Purdie KJ, Pourreyron C, Fassihi H, Cepeda-Valdes R, Frew JW, Volz A, et al. No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullos-associated squamous cell carcinoma. J Invest Dermatol 2010;130: 2853-5.
13. Smoller BA, McNutt NS, Carter DM, Gottlieb AB, Hsu A, Krueger J. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype: implications for carcinogenesis. Arch Dermatol 1990;126:78-83. (Pubitemid 20040987)
14. Tyring SK, Chopra V, Johnson L, Fine JD. Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa. Arch Dermatol 1989;125:797-800. (Pubitemid 19161124)
15. Watt SA, Pourreyron C, Purdie K, Hogan C, Cole CL, Foster N, et al. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma. Oncogene 2011;30: 4666-77.
16. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, HarringtonK, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007;9:1392-400. (Pubitemid 350201752)
17. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848-51. (Pubitemid 38174665)
18. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumorpromoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010;17:135-47.
19. Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A 1990;87:75-9.
20. Arbeit JM, Olson DC, Hanahan D. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene 1996;13:1847-57. (Pubitemid 26397443)
21. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-10. (Pubitemid 34679544)
22. Larouche D, Paquet C, Fradette J, Carrier P, Auger FA, Germain L. Regeneration of skin and cornea by tissue engineering. Methods Mol Biol 2009;482:233-56.
23. Beer TW, Shepherd P, Theaker JM. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology 2000;37:218-23.
24. Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006;5:1640-6.
25. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6: 392-401.
26. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004;2:E7.
27. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002;99:12877-82.
28. Schor SL, Schor AM, Durning P, Rushton G. Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels. J Cell Sci 1985;73:235-44. (Pubitemid 15055073)
29. Commandeur S, Ho SH, de Gruijl FR, Willemze R, Tensen CP, El Ghalbzouri A. Functional characterization of cancer-associated fibroblasts of human cutaneous squamous cell carcinoma. Exp Dermatol 2011;20:737-42.
30. Breuls RG, Klumpers DD, Everts V, Smit TH. Collagen type V modulates fibroblast behavior dependent on substrate stiffness. Biochem Biophys Res Commun 2009;380:425-9.
31. Izu Y, Sun M, Zwolanek D, Veit G, Williams V, Cha B, et al. Type XII collagen regulates osteoblast polarity and communication during bone formation. J Cell Biol 2011;193:1115-30.
32. Berendsen AD, Bronckers AL, Smit TH, Walboomers XF, Everts V. Collagen type V enhances matrix contraction by human periodontal ligament fibroblasts seeded in three-dimensional collagen gels. Matrix Biol 2006;25:515-22. (Pubitemid 44751449)
33. Ricard-Blum S, Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol (Paris) 2005;53: 430-42. (Pubitemid 41112079)
34. Kopp MU, Croci LP, Trueb B. Down-regulation of collagen XII in transformed mesenchymal cells. Int J Cancer 1995;60:275-9.
35. Wang J, Levenson AS, Satcher RL Jr. Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis. Int J Mol Med 2006;17:849-56.
36. Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, et al. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget 2012;3: 267-85.
37. Saadi A, Shannon NB, Lao-Sirieix P, O'Donovan M, Walker E, Clemons NJ, et al. Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci U S A 2010;107:2177-82.
38. Roepman P, de Koning E, van Leenen D, de Weger RA, Kummer JA, Slootweg PJ, et al. Dissection of a metastatic gene expression signature into distinct components. Genome Biol 2006;7:R117.
39. Streuli CH, Bissell MJ. Expression of extracellular matrix components is regulated by substratum. J Cell Biol 1990;110:1405-15.
40. Martins VL, Vyas JJ, Chen M, Purdie K, Mein CA, South AP, et al. Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J Cell Sci 2009;122:1788-99.
41. Javaherian A, Vaccariello M, Fusenig NE, Garlick JA. Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium. Cancer Res 1998;58:2200-8. (Pubitemid 28232909)
42. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231-45. (Pubitemid 27167310)
43. DeNardo DG, Johansson M, Coussens LM. Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 2008;27:11-8.
44. Wallace JA, Li F, Leone G, Ostrowski MC. Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. Cancer Res 2011;71:1203-7.
45. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol 2002;27:616-23. (Pubitemid 35454216)
46. Wetzels RH, Robben HC, Leigh IM, Schaafsma HE, Vooijs GP, Ramaekers FC. Distribution patterns of type VII collagen in normal and malignant human tissues. Am J Pathol 1991;139:451-9.
47. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II: other organs. J Am Acad Dermatol 2009;61:387-402; quiz 403-4.
48. Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011;17:320-9.
49. Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, et al. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc Natl Acad Sci U S A 1998;95: 14769-74. (Pubitemid 29003705)
50. Inman GJ. Switching TGFbeta from a tumor suppressor to a tumor promoter. Curr Opin Genet Dev 2011;21:93-9.